LAB vs MKTX · rev $174.4M vs P/E 13, rev $817.1M
Standard Biotools Inc (LAB) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
LAB currently screens at market cap $317.1M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the LAB and MKTX stock pages for the full models.
Not investment advice.